The effects of ozone therapy and coenzyme Q₁₀ combination on oxidative stress markers in healthy subjects.
BACKGROUND
Ozone therapy is employed as a therapeutic agent in various diseases. Since ozone itself is a radical, using a small dosage of it is known to create an oxidative preconditioning in the body and trigger a strong antioxidant response against that. Coenzyme Q(10), as a strong antioxidant agent, is delivered as a supportive factor in many diseases involving oxidative stress.


OBJECTIVE
The aim of the study was to evaluate the effects of the combination treatment over oxidative stress in healthy individuals.


METHODS
In the current study, 11 healthy volunteers were administered a combination of ozone therapy and Q(10) for 1 month. Blood samples were collected first right after the initial ozone therapy and then 1 month after the ozone therapy + coenzyme Q(10) treatment. We measured erythrocyte superoxide dismutase and catalase enzyme activities along with serum malondialdehyde levels.


RESULTS
Compared with the pretreatment values, an increase was determined in the erythrocyte superoxide dismutase and catalase enzyme activities. However, malondialdehyde, an indicator of oxidative membrane damage, showed a reduction after the combination treatment.


CONCLUSIONS
The results of this study reveal the beneficial effects of ozone therapy + coenzyme Q(10) combination in prevention of oxidative damage.
Department of Biochemistry, Medicine Faculty, Osmangazi University, 26480 Meselik, Eskisehir, Turkey. minal@ogu.edu.tr
M
M
Inal
A
A
Dokumacioglu
E
E
Özcelik
O
O
Ucar
D000328:Adult; D005260:Female; D006801:Humans; D008315:Malondialdehyde / Q000097:blood; D008875:Middle Aged; D010083:Oxidants, Photochemical / Q000494:pharmacology* / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects*; D010126:Ozone / Q000494:pharmacology* / Q000627:therapeutic use; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use
D010083:Oxidants, Photochemical; D014451:Ubiquinone; D008315:Malondialdehyde; D010126:Ozone; C024989:coenzyme Q10
Br J Biomed Sci. 2007;64(1):44-9
17444419
J Biol Regul Homeost Agents. 1996 Apr-Sep;10(2-3):31-53
9250885
Arch Med Res. 2007 Jul;38(5):571-8
17560465
Mediators Inflamm. 2005 Aug 31;2005(4):221-7
16192672
Anal Biochem. 1979 Jun;95(2):351-8
36810
Mitochondrion. 2007 Jun;7 Suppl:S41-50
17482888
Pharmacol Res. 2001 Nov;44(5):391-6
11712870
Free Radic Biol Med. 2002 Sep 1;33(5):627-38
12208349
Mediators Inflamm. 2005 Feb 24;2005(1):16-22
15770062
Eur Heart J. 2007 Sep;28(18):2249-55
17644511
Int J Biochem Cell Biol. 2005 Jun;37(6):1208-18
15778085
Angiologia. 1993 Jul-Aug;45(4):146-8
8239044
Eur J Pharmacol. 2008 Mar 10;581(3):306-14
18093583
J Card Surg. 2007 Jul-Aug;22(4):339-42
17661780
Eur J Pharmacol. 2007 Jul 2;566(1-3):1-10
17434478
Liver Int. 2004 Feb;24(1):55-62
15102001
Mediators Inflamm. 2004 Dec;13(5-6):307-12
15770045
J Appl Toxicol. 1998 Nov-Dec;18(6):443-8
9840751
Transpl Int. 2005 May;18(5):604-12
15819811
Arch Med Res. 2005 Sep-Oct;36(5):549-54
16099337
J Lab Clin Med. 1975 Feb;85(2):337-41
803541
Inflammation. 2007 Apr;30(1-2):52-8
17372841
Arch Med Res. 2008 Feb;39(2):169-78
18164960
J Int Soc Sports Nutr. 2008 Mar 04;5:8
18318910
Dig Dis Sci. 2001 Nov;46(11):2515-20
11713963
Mediators Inflamm. 1998;7(4):289-94
9792340